Review article · 2025 · Open access

An overview of the feasibility of nanomedicine in pancreatic cancer theranostics

Kyriakos Kokkinogoulis, Aristomenis Kollas, David Simeonidis, Pavlos Papakostas, Kalliopi Platoni, EFSTATHIOS P. EFSTATHOPOULOS, Μersini Μakropoulou

Exploration of Targeted Anti-tumor Therapy, 6, 1002326 · Published 18 June 2025 · DOI 10.37349/etat.2025.1002326

Open PDFView at the publisherCite this paper

In brief

“An overview of the feasibility of nanomedicine in pancreatic cancer theranostics” is a 2025 review article by Kyriakos Kokkinogoulis and 6 co-authors, published in Exploration of Targeted Anti-tumor Therapy. OpenAlex counts 4 citations as of 21 November 2026, which puts it in the top 8% of works published in 2025 by citations. It is open access under a CC BY licence: the full text is free to read at Exploration of Targeted Anti-tumor Therapy.

Citations
4
Most cited in
2025 (2)
Field-weighted impact
0.23
References
117
Authors
7

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is among the top causes of cancer-induced mortality, frequently diagnosed too late to be treated effectively, due to the poor prognosis and the limited successful therapeutic options. Apart from the conventional treatments, new multimodal therapies have emerged utilizing different scientific fields for the improvement of the survival and quality of patients' lives. The advancement of nanotechnology leads the way to more personalized medicine and the use of targeted theranostics carriers for deep-seated cancers such as PDAC. New nanotechnology innovations such as specialized photo-sensitizing drug nanocarriers, can effectively improve photodynamic therapy (PDT) of PDAC and enhance phototherapy's action through surface plasmon resonance phenomenon, as another recently re-emerged non- or minimally invasive possible treatment of such diseases. Despite the scientific advancements, significant hurdles remain and many parameters need to be examined. However, the novel application of nano-biophotonic techniques and the convergence of different science fields offer promise for the treatment of difficult-to-treat diseases, like PDAC.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Kokkinogoulis, K., Kollas, A., Simeonidis, D., Papakostas, P., Platoni, K., EFSTATHOPOULOS, E. P., & Μakropoulou, Μ. (2025). An overview of the feasibility of nanomedicine in pancreatic cancer theranostics. Exploration of Targeted Anti-tumor Therapy, 6, 1002326. https://doi.org/10.37349/etat.2025.1002326

MLA 9

Kokkinogoulis, Kyriakos, et al. “An overview of the feasibility of nanomedicine in pancreatic cancer theranostics.” Exploration of Targeted Anti-tumor Therapy, vol. 6, 2025, p. 1002326. https://doi.org/10.37349/etat.2025.1002326.

Chicago

Kokkinogoulis, Kyriakos, Aristomenis Kollas, David Simeonidis, Pavlos Papakostas, Kalliopi Platoni, EFSTATHIOS P. EFSTATHOPOULOS, and Μersini Μakropoulou. 2025. “An overview of the feasibility of nanomedicine in pancreatic cancer theranostics.” Exploration of Targeted Anti-tumor Therapy 6: 1002326. https://doi.org/10.37349/etat.2025.1002326.

Harvard

Kokkinogoulis, K. et al. (2025) ‘An overview of the feasibility of nanomedicine in pancreatic cancer theranostics’, Exploration of Targeted Anti-tumor Therapy, 6, p. 1002326. doi:10.37349/etat.2025.1002326.

IEEE

K. Kokkinogoulis et al., “An overview of the feasibility of nanomedicine in pancreatic cancer theranostics,” Exploration of Targeted Anti-tumor Therapy, vol. 6, p. 1002326, 2025, doi: 10.37349/etat.2025.1002326.

BibTeX

@article{kokkinogoulis2025overview,
  title     = {{An overview of the feasibility of nanomedicine in pancreatic cancer theranostics}},
  author    = {Kokkinogoulis, Kyriakos and Kollas, Aristomenis and Simeonidis, David and Papakostas, Pavlos and Platoni, Kalliopi and EFSTATHOPOULOS, EFSTATHIOS P. and Μakropoulou, Μersini},
  journal   = {Exploration of Targeted Anti-tumor Therapy},
  year      = {2025},
  volume    = {6},
  pages     = {1002326},
  doi       = {10.37349/etat.2025.1002326},
  url       = {https://doi.org/10.37349/etat.2025.1002326}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics

  • pancreatic ductal adenocarcinoma
  • nanomedicine
  • theranostics
  • photodynamic therapy
  • surface plasmon resonance
  • targeted drug delivery
  • multimodal cancer therapy

Work with this paper

Most-cited papers in Engineering

All highly cited Engineering papers

Questions about this paper

How do I cite this paper in APA style?

Kokkinogoulis, K., Kollas, A., Simeonidis, D., Papakostas, P., Platoni, K., EFSTATHOPOULOS, E. P., & Μakropoulou, Μ. (2025). An overview of the feasibility of nanomedicine in pancreatic cancer theranostics. Exploration of Targeted Anti-tumor Therapy, 6, 1002326. https://doi.org/10.37349/etat.2025.1002326

How many times has this paper been cited?

4 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Exploration of Targeted Anti-tumor Therapy: sign in and open the PDF from this page.

Who wrote this paper?

Kyriakos Kokkinogoulis, Aristomenis Kollas, David Simeonidis, Pavlos Papakostas, Kalliopi Platoni, EFSTATHIOS P. EFSTATHOPOULOS, Μersini Μakropoulou.

What is the DOI of this paper?

10.37349/etat.2025.1002326, permanently at https://doi.org/10.37349/etat.2025.1002326. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.